Condensed Statements of Operations - USD ($)	12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Income Statement [Abstract]
Revenue	$ 18,600	$ 5,150
Cost of sales	6,081	2,796
Gross margin	12,519	2,354
Operating expenses:
Research and development	2,878,554	2,460,868
Selling, general and administrative	3,439,735	3,654,450
Total operating expenses	6,318,289	6,115,318
Loss from operations	(6,305,770)	(6,112,964)
Other income (expense)
Interest expense	(354,080)	(243,174)
Other income	54,642	1,848
Total other income (expense)	(299,438)	(241,326)
Net loss	$ (6,605,208)	$ (6,354,290)
Net loss per share, basic	$ (19)	$ (80)
Net loss per share, diluted	$ (19)	$ (80)
Weighted average common shares outstanding, basic	352,520	79,506
Weighted average common shares outstanding, diluted	352,520	79,506